Short cut
 
 
321

Page:


 

Drug discovery and development seminar by Stanislaw Pikul at Nencki

                           

 

The Nencki Institute kindly invites you to a seminar “Drug discovery and development - opportunities for collaboration between companies and research institutes in Poland and worldwide”. The seminar will be given by Stanisław Pikul, PhD and will take place on April 25th at 10 a.m., at the Nencki Institute, hall 2. The event is open to the public but  the number of seats in the lecture hall is limited, therefore we ask you to confirm your attendance by an e-mail to: m.borkowska@nencki.gov.pl.

 

The seminar is organised within the BIO IMAGINE: BIO-IMAGing in research INnovation and Education project.

 

 


 


 

Establishing start-up companies in Life Science sector

                               

 

The Nencki Institute cordially invites you to a series of workshops dedicated to the establishment and development of companies in the broad areas of biomedicine and biotechnology. Workshops are targeted specifically for scientists and PhD students who lead or are establishing their own business, or for those who are considering such a possibility in the future. Workshops will be held by Roland Kozlowski, PhD and will take place on  April 18th and 19th at 10 a.m., at the Nencki Institute, hall 2. The number of seats in the lecture hall is limited, therefore we ask you to confirm your attendance by an e-mail to m.borkowska@nencki.gov.pl.

The seminar is organised as a part of BIO-IMAGINE project.
 

 

 

 

Two seminars will be executed.  The first “Pre-requisites for success in a life science start-up” will describe the generally perceived requisites for successful development of life science start-up companies.  Dr Kozlowski intends the seminar to be interactive and will endeavour to initiate audience participation and discussion based around key principals.  So please wear your entrepreneurial hats and be prepared to ask questions.  The  second: “Lectus Therapeutics Limited - a case study from start-up to sale” will be a case study of one or two (if time allows) businesses Dr Kozlowski has initiated.  The activities of the businesses will be put into perspective of the markets at that particular point in time. Dr Kozlowski will present the ”official version” based on press releases and publically available information and then talk about what it really “feels like” to run a venture capital backed business.  Again please be prepared for an interactive session.  Finally a short anonymous presentation will be given on the careers Dr Kozlowski’s students have forged and the opportunities that life science has for graduates. “

Dr Roland Kozlowski
Roland Kozlowski received a first class honours degree from the University of Bath and a PhD from the University of Cambridge.
Roland Kozlowski is a bioentrepreneur who has worked in the industry for approaching two decades. Roland has held a number of operational roles including most recently Chief Executive Officer and a founder of Lectus Therapeutics Limited (investor exit via asset sale to UCB in Q4, 2011), Chief Executive Officer and co-founder of Sense Proteomic Limited (trade sale to Procognia Limited in Q1, 2003). In the mid 1990s Roland worked with Oxford Molecular PLC on their cornerstone deal he negotiated with Yamanouchi Pharmaceutical Co., Ltd. During his career Roland has gained considerable transactional experience ranging from company sale, purchase, financing and in- and out-licensing and commercialisation of technology. In the past Roland ran a Research Groups at the University of Oxford and University of Bristol where subsequently he was a Visiting Industrial Professor.  He has published and patented in the field of ion channel physiology and pharmacology. Roland has served on the boards of a number of companies including the Bio Industry Association in the UK.  He remains a non-executive director of Lectus Therapeutics Limited, is a non-executive director of London Genetics Limited which operates in the personalised medicine space and owner of Life Science Biznes Consulting (LSBC) Sp. z o. o. a Central European Strategic Advisory Firm.
 


 

"Patenting and searching patent databases workshops" at the Nencki Institute


Nencki Insitute is organizing workshops on patenting with help of European Patent Office.

On 9th and 10th October the Nencki Institute of Experimental Biology will host dr Nigel Clarke from European Patent Office, that will teach our scientist basics on intellectual property rights and patenting as well as how to search patent databases.

 

Workshops programme



 

From algorithm to arrhythmia: does MP3 have anything in common with ECG? How a PhD student became a CEO – a true story.

 

 

This case study will show how a Polish invention conquered the American market. This will be an interactive seminar on the challenges encountered when starting your own business targeting a global market. The event will take place on July 5 at 11 am, at the Nencki Institute, hall 2. Everyone is welcome, especially PhD students and young researchers with innovative ideas. Limited seating available, please register by mail with m.borkowska@nencki.gov.pl.

The seminar will be given by Marcin Szumowski, PhD, co-founder, vice president (2005-2007) and president (2007-2009) of Medicalgorithmics SA, founder and president of Europroject Management Consulting and director of the Office of International Cooperation and Project Management at the Nencki Institute of Experimental Biology, creator and leader of the Technology Transfer Platform, established on the basis of the CePT Scientific Consortium. During the past 15 years Dr Szumowski has prepared or contributed to over 60 applications, business plans, has managed or executed over 40 research, R&D, targeted and investment projects with the total value of close to 1 billion PLN.

This seminar is organised under the National Centre for Research and Development Innovativeness Creator Programme executed by the Nencki Institute.


 

How to have your cake and eat it – the reality of commercialization of research results

We kindly invite you to a lecture on commercialization of research results in the area of biomedical imaging, which will take place on the May 30 at 2 p.m., at the Nencki Institute, hall 2. The seminar will be given by Maciej Wojtkowski, PhD, an established expert in optics and its applications in biomedical imaging. The event is open to the public but the number of seats in the lecture hall is limited, therefore we ask you to confirm your attendance by an e-mail to m.borkowska@nencki.gov.pl. The workshop is organised within the National Centre for Research and Development’s Innovativeness Creator Programme – realized by the Nencki Institute.

 

Maciej Wojtkowski (b.1975) received his MSc and PhD in physics from Nicholas Copernicus University (NCU), Torun, Poland. Presently he has a faculty position of research assistant professor in the Institute of Physics, NCU, Poland. His research interest includes optical coherence tomography and low coherence interferometry applied to biomedical imaging. He is active in the field of Optical Coherence Tomography (OCT) and its ophthalmic applications.

Dr Wojtkowski has significant impact on development of Fourier domain OCT (FdOCT) technique. The first FdOCT instrument for in vivo retinal imaging was designed and constructed by dr Wojtkowski and his colleagues from the Medical Physics Group at Nicolaus Copernicus University Poland in 2001.  Application of high speed OCT to ophthalmology enabled group from Torun obtaining retinal cross-sectional images with the shortest exposure times and in turn it allowed proving speed and sensitivity advantage of Fourier domain detection over standard OCT method. Dr Wojtkowski also contributed in development and construction of three clinical prototypes high speed and high resolution OCT instruments which are in use in ophthalmology clinics: in Collegium Medicum in Bydgoszcz, Poland, New England Eye Center, Boston, USA, and UPMC Pittsburgh.

During his academic career Dr Wojtkowski served short internships in Vienna University and University of Kent. He also worked for two years as postdoctoral fellow in joint project between Massachusetts Institute of Technology and New England Eye Center.


 

Valuation of intellectual property workshop

We are kindly inviting you to workshops on intellectual property valuation, which will take place at the Nencki Institute on 21-22nd November and 19-20 December. The aim of the training is specialist education of representatives of the academia how to value new technologies in order to enhance the proecess of their commercialization. The workshops will be held by Mr Andrzej Podszywałow- a renowned specialist in this discipline. The trainning is free and open but the number of available places is strictly limited. Interested participants are requested to send their request by e-mail (a.bialkowski-miler@nenkcki.gov.pl) or express their interrest direcly at the Office of International Cooperation and Project Management (rook 17a). The workshop is being organised within a framework of the "Kreator Innowacyjności" programme.


 

Amendment of the Intellectual Property Rights Policy

We would like to bring your attention to the fact that on July 27, 2011 the Director of the Nencki Institute, prof. Adam Szewczyk, approved amendments to the Intellectual Property Rights Policy at the Institute. The amended Policy contains provisions related to the new Polish Academy of Sciences Act of April 30, 2011 (Dz. U. Nr 96, poz 619) and explicitly includes all PhD students. Moreover, the updated policy satisifies some practical requirements arising from rapod development of cooperation with other Mazovian scientific institutions and enterprises within the emerging bio-tech-med cluster - BTM Mazowsze


 

Nencki Institute is getting more innovative

We are pleased to announce the fast growth of innovation activity of scientists working at the Nencki Institute that results from measures undertaken under the scope of the Nencki Institute Innovation Platform and cooperation with the BTM Mazovia cluster. Since inauguration of NIIP in January 2010 there have been altogether 25 innovative projects (inventions and service offers) identified. 16 of them were written down and formally submitted to the Office of International Cooperation and Project Management. 5 of the identified inventions were submitted as patent applications- three to the European Patent Office, and two to Polish Patent Office. Protection of one of those inventions was already extended through entrance into the PCT phase. Two subsequent patent applications are under preparation.

 

Those actions resulted in establishing cooperation with two enterprises- Laboratorium Kosmetyczne dr Irena Eris and an IT company Netiology- as well as jointly preparing with the above mentioned companies and the BTM Mazowsze three projects within the scope of the InnoTech programme of the National Centre for Research and Development (pol. NCBiR).

 

The recently submitted inventions were related to programs, algorithms and methods in the microscopy imaging field. Prof. Elżbieta Wyroba and Rafał Bartosiewicz created a method for three dimensional imaging of microstructures using electron microscopy. Prof. Grzegorz Wilczynski and Błażej Ruszczycki, PhD created a method and a program for segmenting and analyzing a 3D image (eg. from a confocal microscope) comprising round objects such as cell nuclei. Finally, the team consisting of prof. Leszek Kaczmarek, Błażej Ruszczycki PhD and Jakub Włodarczyk, PhD created a semiautomatic method and program for processing an image comprising dendritic spines.

 

A significant success of the Nencki Institute is also completion of the merit part of evaluation of the invention “A transgenic animal and a method of producing it” in front of the EPO. Because of positive outcome, we are awaiting formally acknowledging the first foreign patent of the Nencki Institue shortly. The procedure is financed by the activity 1.3.2 of the Operational Programme Innovative Economy.

 

We are encouraging scientists interested in evaluation of the commercial potential of their projects to contact Dorota Gierej or Andrzej Bialkowski-Miler, who are available through the Office of International Cooperation and Project Management.


 

BioImagine EMBLEM Seminars

 

DAY 1 – 31.05.2011 (Tuesday) – Nencki Institute of Experimental Biology PAS

 

 

 

10.00 – 11.30 – Workshop part 1

 

11.30 – 12.00 – Coffee Break

 

12.00 – 13.30 – Workshop part 2

 

13.30 – 14.30 – Lunch

 

 

Workshop

 

Dr. Martin Raditch

 

Add value to knowledge” (duration 3 h)

This workshop will show examples how to add value to existing research programs and inventions of your institutions using the technology transfer toolbox. Further more you will get ideas, how to set-up the contractual and financial frame-work and last but not least you will have the chance to learn from success stories as well as failures in form of case studies.

 

 

 

 

DAY 2 – 02.06.2011 (Thursday) – Nencki Institute of Experimental Biology PAS

 

 

 

10.30 – 12.00 – ““Introduction to Intellectual Property Rights and Technology Transfer”

 

Dr. Gábor Lamm

Dr. Birgit Kerber 

(duration 60 minutes)

 

This general seminar describes the technology transfer process in an academic basic research setting; gives an overview (with examples) about the different types of Intellectual Property Rights (IPR); the criteria required for filing patent application(s); and what Material Transfer Agreements (MTAs) and Confidentiality [Non-Disclosure] Agreements (CDAs/NDAs) are good for. The seminar also covers the “does” and “don’ts” for innovators working in an academic setting and what to watch out for when dealing with commercial partners.

 

 

12.00 – 12.30 – Coffe Break

 

12.30 – 14.30 - “Function defines Structure: how to set-up a successful Technology Transfer Office”

 

Dr. Gabor Lamm

(duration 90 minutes)

 

Is Technology Transfer (TT) best managed as an internal activity of the University/Research Institute or as an external entity? How should the TT activities be structured and managed?  How do you find that rare specimen, the TT-officers, with one leg in industry and the other in academia? And once you recruit them, how do you manage to motivate and retain them? This specialised seminar aims to provide answers to all of these questions and is aimed at high-level decision makers at Universities and Research Institutes, Politicians and Technology Transfer Professionals.

 

 

14.30 – 15.30 Lunch

 

 

 

 

 

EMBLEM Technology Transfer GmbH

 

Martin Raditsch, PhD

Deputy Managing Director

 

 

Martin Raditsch is a graduate of Heidelberg University and holds a Ph.D. in Molecular Biology.

Following his Ph.D., Martin was Laboratory Leader in the pharmaceutical R&D division of BASF AG. After positions in international product marketing in the agrochemical sector of the corporation and plant biotech project management, he became Head of Technology Management and was responsible for the applied technology portfolio of the plant biotech entity with activities based in the US, Canada, Sweden and Germany.

In July 2001 Martin joined EMBL Enterprise Management Technology Transfer GmbH (EMBLEM) (www.embl-em.de), a fully owned subsidiary of the European Molecular Biology Laboratory (EMBL) (www.embl.de) as Head of Business Development responsible for the commercialisation of intellectual property developed in the EMBL-world. As of January 2004 he is Deputy Managing Director of EMBLEM.

Martin is an alumnus of the Max-Planck-Society, the St. Gallen Business School and a member of several professional societies such as LES, ASTP.

 

Gábor M. Lamm, Ph.D

Managing Director

 

Dr. Lamm (born 1967 in Budapest) is a graduate of Edinburgh University (Biochemistry) and holds a Ph.D. in Molecular Biology.

After spending three years as a research scientist at the Boehringer Ingelheim Institute of Molecular Pathology (IMP) in Vienna, Dr. Lamm joined Wacker Chemie, a major global supplier of silicone and polymer raw materials and semi-conductors. At Wacker Chemie, Dr. Lamm was Business-Team Leader in the division specialising in advanced ceramic components for high-tech applications. As of October 2000 he is Managing Director of EMBL Enterprise Management Technology Transfer GmbH (EMBLEM; http://www.embl-em.de), the wholly owned subsidiary of the European Molecular Biology Laboratory (EMBL; www.embl.org).

Dr. Lamm is an alumnus of the European Molecular Biology Laboratory Ph.D. program and of the Boehringer Ingelheim Fonds and is co-founder of the EMBL Technology Fund (ETF) [www.embl-ventures.com]. He is on the board of directors of the BioRegio RND e. V. (Heidelberg) and former vice-president (2002-2006) of the Association of European Science and Technology Transfer Professionals (ASTP).

 

 

 

 

 

 

Birget Kerber, Ph.D

EMBLEM Business Development Manager

 

 

Dr. Kerber is a graduate of Marburg University (Molecular Genetics). She did her Ph.D. thesis at the Max-Planck-Institute for biophysical chemistry in Göttingen and was awarded a Ph.D. in Biology in 1998.

After spending three years as a postdoctoral scientist at the European Molecular Biology Laboratory in Heidelberg (EMBL), Dr. Kerber joined EMBL Enterprise Management Technology Transfer GmbH in 2001, where she currently is Business Development Manager. 

For her Ph.D. and postdoctoral work, Dr. Kerber held fellowships of the Boehringer Ingelheim Fonds, the Deutsche Forschungsgemeinschaft (DFG) and the European Molecular Biology Organisation (EMBO).  Dr. Kerber is a member of the Association of European Science and Technology Transfer Professionals (ASTP) and of the Licensing Executives Society (LES).

 

 

 

About EMBLEM (http://www.embl-em.de/)

 

EMBL Enterprise Management Technology Transfer GmbH (EMBLEM) is an affiliate and the commercial arm of the European Molecular Biology Laboratory (EMBL). EMBL established in 1974 is a basic research institute funded by public research funds from 20 member states, including most of the EU, Switzerland and Israel. EMBLEM identifies, protects and commercialises the intellectual property developed in the EMBL-world, from EMBL-alumni and from non-EMBL third parties. EMBLEM facilitates and accelerates the transfer of innovative technology from basic research to industry by working closely with industrial partners spanning the biotech, pharmaceutical, IT and mechanical/electrical engineering markets.

 

 

EMBL(http://www.embl-heidelberg.de)

The European Molecular Biology Laboratory (EMBL) is a basic research institute funded by public research funds from 20 member states, including most of the EU, Switzerland and Israel. Research at EMBL is conducted by approximately 80 independent groups, covering the spectrum of molecular biology. The Laboratory has five units: the main Laboratory in Heidelberg, Outstations in Hinxton (the European Bioinformatics Institute), Grenoble (on the campus of the ILL and ESRF), Hamburg (on the DESY site), and an external research programme in Monterotondo, Italy (sharing a campus with EMMA and the CNR). The cornerstones of EMBL's mission are: to perform basic research in molecular biology, to train scientists, students and visitors at all levels, to offer vital services to scientists in the member states, and to develop new instruments, technologies and methods in the life sciences. The Laboratory also sponsors an active Science and Society programme.

 

For registration please contact Mr. Paweł Nowicki

 

Office of International Cooperation

and Project Management

 

Nencki Institute of Experimental Biology

Polish Academy of Sciences

 

Pasteura 3

02-093 Warsaw Poland

phone (+48 22) 589 2149 begin_of_the_skype_highlighting            (+48 22) 589 2149      end_of_the_skype_highlighting

fax   (+48 22) 589 2489

mobile (+48) 603 741 752 begin_of_the_skype_highlighting            (+48) 603 741 752      end_of_the_skype_highlighting

e-mail: p.nowicki@nencki.gov.pl

http://www.nencki.gov.pl


 

Bioforum and Bioconnect 2011

We would like to kindly invite all the interested parties to the Bioforum trade fair and its satelite conference Bioconnect 2011.

 

Bioforum is the biggest event in Central and Eastern Europe biobusiness community.

 

Bioconnect is a specialist conference on life science applied reasearch and its commercialisation. The conference moderator is Marcin Szumowski, PhD, head of the Office of  International Cooperation and Project Management at the Nencki Institute and a co-founder of MedicAlgorithmics, a spin-off company.

 

More information: http://www.bioforum.pl/2011/ and http://www.ntpp.pl/bioconnect-2011/home/


321

Page:






 

Nencki Institute of Experimental Biology
Polish Academy of Sciences
3 Pasteur St.
02-093 Warsaw
Poland

Director of the Institute
phone.: (+48 22) 659 85 71
fax: (+48 22) 822 53 42
e-mail: dyrekcja@nencki.gov.pl

Office of International Cooperation
and Project Management

phone: (+48 22) 5892 263/ 149
fax: (+48 22) 5892 489
m.szumowski[at]nencki.gov.pl
p.nowicki[at]nencki.gov.pl